Survey Reveals Bostonians are Biotech-Savvy
Biotech News
Survey Reveals Bostonians are Biotech-Savvy
But Two-Thirds of Boston Residents Unaware of Local World-Class Biotech Facility
WORCESTER, Mass., May 3 -- A new survey reveals that Bostonians command a surprising general knowledge of biotechnology.
The survey, conducted by Kelton Research for Abbott (NYSE: ABT), a global healthcare company, also found that there is significant lack of awareness that one of the world's leading biotechnology research facilities is located in Boston's backyard.
Key Findings
Bostonians understand biotechnology's importance but have more to learn about the topic:
-- Close to two thirds of Bostonians (64 percent) could correctly define
biotechnology as the "use of biology and technology"
-- More than three quarters of Bostonians (77 percent) grasp that the
field of medicine has been revolutionized by the application of
biotechnology
-- Ninety percent of Bostonians agree that biotechnology is responsible
for developing better medicines
-- But Bostonians greatly overestimate the amount of time it takes to
produce biologic medicines. Nearly two-thirds (61 percent) think that
it takes more than a year to produce/manufacture these medicines.
While the research and development process for any medicine, including
biologics, can take up to 10 years, it generally takes about six weeks
to produce/manufacture many types of biologic medicines. Less than one
percent of Bostonians answered this question correctly.
Boston residents are unaware of local contributions to biotechnology.
-- Two-thirds (66 percent) of Bostonians did not know that one of the
world's premier biotechnology research facilities is based in
Worcester. Worcester is home to Abbott's Bioresearch Center.
-- Nearly four in 10 Bostonians (38 percent) were surprised to learn that
a biotech research and manufacturing facility is in their backyard.
"People appreciate biotechnology's contribution and what it can do for
them, but they assume it's being discovered and produced somewhere else,"
said Peter Isakson, Ph.D. and divisional vice president, Immunology
Research at Abbott's Worcester-based Bioresearch Center. "Groundbreaking
discoveries that address rheumatoid arthritis, Crohn's disease and
psoriasis happen right here in Worcester,"
Boston believes biotech improves quality of life:
-- Nearly all Bostonians (94 percent) think that biotechnology research in
the greater Boston area will lead to new medical options
-- Some Bostonians would take drastic steps to alleviate chronic pain
associated with diseases that biologic medicines may help treat -- 15
percent reported they would never take another raise, give up five
years of their life or never retire. Fourteen percent would work
Saturdays for the rest of their life; and nine percent would never take
another vacation.
-- Bostonians agreed that certain types of chronic pain would make it
difficult to live a normal life, including headaches (40 percent),
joint pain (29 percent), and bowel pain (19 percent)
"Abbott is committed to novel treatments for serious conditions," said
John Leonard, M.D., vice president, Global Research and Development,
Abbott, and BIO Board Member. "Our scientists are at the forefront of
research and discovery in inflammatory diseases, oncology and neuroscience,
researching and manufacturing biologic medicines that address unmet medical
needs for people around the world."
About Abbott at BIO 2007
Abbott is a sponsor of the Biotechnology Industry Organization (BIO)
2007 convention, May 6-9, 2007, in Boston.
About Abbott
Abbott is a global, broad-based health care company devoted to the
discovery, development, manufacture and marketing of pharmaceuticals and
medical products, including nutritionals, devices and diagnostics. The
company employs 65,000 people and markets its products in more than 130
countries.
The Abbott-BIO 2007 Biotechnology survey was conducted by Kelton
Research via telephone to 500 Boston areas residents between April 6th and
16th. Quotas were set to ensure reliable and accurate representation of the
total Boston population age 18 and above. For this study, the margin of
error f is +/- 4.4 percent with a 95 percent confidence level.
SOURCE Abbott
Survey Reveals Bostonians are Biotech-Savvy
But Two-Thirds of Boston Residents Unaware of Local World-Class Biotech Facility
WORCESTER, Mass., May 3 -- A new survey reveals that Bostonians command a surprising general knowledge of biotechnology.
The survey, conducted by Kelton Research for Abbott (NYSE: ABT), a global healthcare company, also found that there is significant lack of awareness that one of the world's leading biotechnology research facilities is located in Boston's backyard.
Key Findings
Bostonians understand biotechnology's importance but have more to learn about the topic:
-- Close to two thirds of Bostonians (64 percent) could correctly define
biotechnology as the "use of biology and technology"
-- More than three quarters of Bostonians (77 percent) grasp that the
field of medicine has been revolutionized by the application of
biotechnology
-- Ninety percent of Bostonians agree that biotechnology is responsible
for developing better medicines
-- But Bostonians greatly overestimate the amount of time it takes to
produce biologic medicines. Nearly two-thirds (61 percent) think that
it takes more than a year to produce/manufacture these medicines.
While the research and development process for any medicine, including
biologics, can take up to 10 years, it generally takes about six weeks
to produce/manufacture many types of biologic medicines. Less than one
percent of Bostonians answered this question correctly.
Boston residents are unaware of local contributions to biotechnology.
-- Two-thirds (66 percent) of Bostonians did not know that one of the
world's premier biotechnology research facilities is based in
Worcester. Worcester is home to Abbott's Bioresearch Center.
-- Nearly four in 10 Bostonians (38 percent) were surprised to learn that
a biotech research and manufacturing facility is in their backyard.
"People appreciate biotechnology's contribution and what it can do for
them, but they assume it's being discovered and produced somewhere else,"
said Peter Isakson, Ph.D. and divisional vice president, Immunology
Research at Abbott's Worcester-based Bioresearch Center. "Groundbreaking
discoveries that address rheumatoid arthritis, Crohn's disease and
psoriasis happen right here in Worcester,"
Boston believes biotech improves quality of life:
-- Nearly all Bostonians (94 percent) think that biotechnology research in
the greater Boston area will lead to new medical options
-- Some Bostonians would take drastic steps to alleviate chronic pain
associated with diseases that biologic medicines may help treat -- 15
percent reported they would never take another raise, give up five
years of their life or never retire. Fourteen percent would work
Saturdays for the rest of their life; and nine percent would never take
another vacation.
-- Bostonians agreed that certain types of chronic pain would make it
difficult to live a normal life, including headaches (40 percent),
joint pain (29 percent), and bowel pain (19 percent)
"Abbott is committed to novel treatments for serious conditions," said
John Leonard, M.D., vice president, Global Research and Development,
Abbott, and BIO Board Member. "Our scientists are at the forefront of
research and discovery in inflammatory diseases, oncology and neuroscience,
researching and manufacturing biologic medicines that address unmet medical
needs for people around the world."
About Abbott at BIO 2007
Abbott is a sponsor of the Biotechnology Industry Organization (BIO)
2007 convention, May 6-9, 2007, in Boston.
About Abbott
Abbott is a global, broad-based health care company devoted to the
discovery, development, manufacture and marketing of pharmaceuticals and
medical products, including nutritionals, devices and diagnostics. The
company employs 65,000 people and markets its products in more than 130
countries.
The Abbott-BIO 2007 Biotechnology survey was conducted by Kelton
Research via telephone to 500 Boston areas residents between April 6th and
16th. Quotas were set to ensure reliable and accurate representation of the
total Boston population age 18 and above. For this study, the margin of
error f is +/- 4.4 percent with a 95 percent confidence level.
SOURCE Abbott
posted by Famous Quotations - Survey Reveals Bostonians are Biotech-Savvy
0 Comments:
Post a Comment
Links to this post:
Create a Link
<< Home